Bank of New York Mellon Corp - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 76 filers reported holding FIBROGEN INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$269,644
-69.1%
312,485
-3.5%
0.00%
Q2 2023$873,909
-83.6%
323,670
+13.2%
0.00%
-100.0%
Q1 2023$5,337,041
+12.8%
286,015
-3.1%
0.00%0.0%
Q4 2022$4,729,937
+21.7%
295,252
-1.2%
0.00%0.0%
Q3 2022$3,888,000
+37.2%
298,870
+11.4%
0.00%0.0%
Q2 2022$2,833,000
-16.1%
268,329
-4.5%
0.00%0.0%
Q1 2022$3,376,000
-13.8%
280,862
+1.1%
0.00%0.0%
Q4 2021$3,918,000
+8.3%
277,860
-21.5%
0.00%0.0%
Q3 2021$3,617,000
-93.6%
353,949
-83.4%
0.00%
-90.9%
Q2 2021$56,867,000
-29.7%
2,135,418
-8.4%
0.01%
-35.3%
Q1 2021$80,942,000
+22.1%
2,331,898
+30.5%
0.02%
+21.4%
Q4 2020$66,292,000
+0.4%
1,787,336
+11.3%
0.01%
-12.5%
Q3 2020$66,011,000
+7.8%
1,605,306
+6.2%
0.02%0.0%
Q2 2020$61,247,000
+60.1%
1,511,187
+37.3%
0.02%
+23.1%
Q1 2020$38,257,000
-21.9%
1,100,934
-3.7%
0.01%0.0%
Q4 2019$49,016,000
+40.7%
1,142,813
+21.3%
0.01%
+30.0%
Q3 2019$34,829,000
-18.5%
941,829
-0.4%
0.01%
-16.7%
Q2 2019$42,728,000
-1.0%
945,745
+19.1%
0.01%0.0%
Q1 2019$43,165,000
+57.3%
794,216
+34.0%
0.01%
+33.3%
Q4 2018$27,439,000
+34.7%
592,897
+76.8%
0.01%
+80.0%
Q3 2018$20,373,000
-3.6%
335,367
-0.6%
0.01%
-16.7%
Q2 2018$21,127,000
+33.9%
337,484
-1.2%
0.01%
+50.0%
Q1 2018$15,784,000
-0.0%
341,636
+2.6%
0.00%0.0%
Q4 2017$15,789,000
-20.6%
333,096
-9.9%
0.00%
-20.0%
Q3 2017$19,884,000
+110.4%
369,599
+26.3%
0.01%
+66.7%
Q2 2017$9,452,000
+57.1%
292,636
+19.9%
0.00%
+50.0%
Q1 2017$6,018,000
+19.4%
244,141
+3.7%
0.00%
+100.0%
Q4 2016$5,040,000
+7.4%
235,507
+3.9%
0.00%0.0%
Q3 2016$4,692,000
+26.4%
226,643
+0.2%
0.00%0.0%
Q2 2016$3,712,000
-29.9%
226,218
-9.0%
0.00%
-50.0%
Q1 2016$5,294,000
-32.4%
248,669
-3.3%
0.00%0.0%
Q4 2015$7,836,000
+46.4%
257,155
+5.3%
0.00%0.0%
Q3 2015$5,352,000
+39.0%
244,174
+49.1%
0.00%
+100.0%
Q2 2015$3,849,000
+221.0%
163,785
+328.8%
0.00%
Q1 2015$1,199,000
+40.9%
38,199
+22.7%
0.00%
Q4 2014$851,00031,1410.00%
Other shareholders
FIBROGEN INC shareholders Q1 2015
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders